NJSHAD - Health Indicator Report - Incidence of Leukemia by Year and Sex, New Jersey, 1990 to 2021

Path:

NJSHAD
Indicator Reports
Report

Indicator Report Data View Options

Data Views:

More Information:

Related Indicator Reports:

Associated Health Topics:

Male
	1	Male	1990	1990	17.6	16.1	19.2	579
	1	Male	1991	1991	17.7	16.3	19.3	584
	1	Male	1992	1992	16.8	15.4	18.3	574
	1	Male	1993	1993	17.2	15.8	18.7	590
	1	Male	1994	1994	17.5	16.1	19.0	597
	1	Male	1995	1995	16.7	15.4	18.2	577
	1	Male	1996	1996	17.4	16.0	18.9	614
	1	Male	1997	1997	17.2	15.9	18.6	627
	1	Male	1998	1998	17.3	15.9	18.7	635
	1	Male	1999	1999	17.6	16.2	19.0	638
	1	Male	2000	2000	16.9	15.6	18.3	629
	1	Male	2001	2001	19.8	18.3	21.2	746
	1	Male	2002	2002	18.2	16.8	19.6	697
	1	Male	2003	2003	18.6	17.2	20.0	720
	1	Male	2004	2004	19.2	17.9	20.7	754
	1	Male	2005	2005	18.1	16.8	19.5	721
	1	Male	2006	2006	18.4	17.1	19.8	744
	1	Male	2007	2007	18.8	17.5	20.2	766
	1	Male	2008	2008	18.4	17.1	19.8	762
	1	Male	2009	2009	18.6	17.3	20.0	786
	1	Male	2010	2010	21.9	20.5	23.4	935
	1	Male	2011	2011	20.5	19.2	21.9	887
	1	Male	2012	2012	20.6	19.3	22.0	909
	1	Male	2013	2013	20.2	18.9	21.6	914
	1	Male	2014	2014	20.4	19.0	21.7	927
	1	Male	2015	2015	21.0	19.6	22.3	970
	1	Male	2016	2016	21.1	19.8	22.5	992
	1	Male	2017	2017	20.7	19.4	22.0	995
	1	Male	2018	2018	20.6	19.3	21.9	1,014
	1	Male	2019	2019	20.3	19.1	21.6	1,007
	1	Male	2020	2020	18.2	17.0	19.4	923
	1	Male	2021	2021	20.3	19.0	21.6	1,036
Female
	2	Female	1990	1990	11.1	10.1	12.1	490
	2	Female	1991	1991	10.6	9.6	11.6	469
	2	Female	1992	1992	10.9	10.0	11.9	500
	2	Female	1993	1993	11.4	10.4	12.4	519
	2	Female	1994	1994	9.9	9.0	10.8	463
	2	Female	1995	1995	10.7	9.8	11.7	507
	2	Female	1996	1996	10.3	9.4	11.2	487
	2	Female	1997	1997	10.8	9.9	11.8	519
	2	Female	1998	1998	10.3	9.4	11.2	497
	2	Female	1999	1999	10.2	9.3	11.1	497
	2	Female	2000	2000	11.1	10.1	12.1	541
	2	Female	2001	2001	10.9	10.0	11.8	544
	2	Female	2002	2002	11.0	10.1	12.0	551
	2	Female	2003	2003	10.9	10.0	11.8	546
	2	Female	2004	2004	11.2	10.3	12.2	580
	2	Female	2005	2005	10.6	9.7	11.6	540
	2	Female	2006	2006	11.7	10.8	12.7	603
	2	Female	2007	2007	11.5	10.5	12.4	590
	2	Female	2008	2008	11.4	10.5	12.3	601
	2	Female	2009	2009	11.1	10.2	12.1	591
	2	Female	2010	2010	12.0	11.1	13.0	645
	2	Female	2011	2011	13.2	12.2	14.3	700
	2	Female	2012	2012	12.5	11.5	13.5	685
	2	Female	2013	2013	12.1	11.2	13.1	681
	2	Female	2014	2014	13.8	12.8	14.9	775
	2	Female	2015	2015	11.8	10.9	12.8	685
	2	Female	2016	2016	12.2	11.3	13.2	697
	2	Female	2017	2017	13.4	12.4	14.4	776
	2	Female	2018	2018	12.2	11.3	13.2	732
	2	Female	2019	2019	11.6	10.7	12.5	698
	2	Female	2020	2020	12.0	11.1	13.0	732
	2	Female	2021	2021	13.0	12.0	13.9	795

Why Is This Important?

Leukemia is a broad term for cancers of the blood cells. Although it is often thought of as a children's disease, leukemia is ten times more common in adults than in children, and more than half of all leukemia cases occur in people over the age of 65.

The type of leukemia depends on the type of blood cell that becomes cancer and whether it grows quickly or slowly. Acute lymphocytic leukemia (ALL) is the most common type of childhood leukemia and also affects adults, especially those age 65 and older. Acute myeloid leukemia (AML) occurs in both adults and children. Chronic lymphocytic leukemia (CLL) most commonly affects adults over age 55, and rarely occurs in children. Chronic myeloid leukemia (CML) occurs mainly in adults.

Definition

Incidence rate of leukemia by sub-type for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.

Data Notes

Data have been age-adjusted to the U.S. 2000 standard population.
Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified.

2020 data are considered preliminary and should not be used in trend analyses; an approximate 10% decrease in the number of cancer cases diagnosed in 2020 and compared to 2019 is partly due to the COVID-19 pandemic. Patients experienced difficulties scheduling medical appointments and cancer screening tests in 2020.

Incidence data for 2021 are considered preliminary due to possible reporting delays.

Data Sources

SEER*Stat, National Center Institute
(https://www.seer.cancer.gov/seerstat)
Bridged-race population estimates, National Cancer Institute
(https://seer.cancer.gov/popdata/)

How the Measure is Calculated

Numerator:
Number of new cases of leukemia by sub-type among a defined population in a specified time interval.
Denominator:
Defined population in a specified time interval.

Related Health Objectives and Indicators

Environmental Public Health Tracking Indicator CA-20

Description: Incidence of leukemia
https://ephtracking.cdc.gov/indicatorPages?selectedContentAreaAbbreviation=9&selectedIndicatorId=20

Related Health Status Outcomes Indicators:

Health Topic Pages Related to: Incidence of Leukemia

Cancer

Official Site of The State of New Jersey

New Jersey State Health Assessment Data

About Health Topics

Select a Community Type

About Community Profiles

Find Any Indicator Report by

Find Select Indicator Reports by

About Health Indicator Reports

Vital Statistics

Health Surveys

Morbidity

About Dataset Queries

Additional Data

Other Resources

Help and Tutorials

Contact, etc.

Incidence of Leukemia by Year and Sex, New Jersey, 1990 to 2021